Evidence map›Paper›PMID 41366658›Full record

ArticleBMC medical imaging2025

A novel strategy for enhanced schizophrenia detection using established CNN architectures.

Ali Allahgholi, Keivan Maghooli, Babak Gholamine

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ali AllahgholiFaculty of Medical Sciences and Technologies, Biomedical Engineering Department, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Keivan MaghooliFaculty of Medical Sciences and Technologies, Biomedical Engineering Department, Science and Research Branch, Islamic Azad University, Tehran, Iran. k_maghooli@srbiau.ac.ir.
Babak GholamineDepartment of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia, a complex psychotic condition, is challenging to diagnose due to its reliance on clinical assessments and behavioral evaluations. Neuroimaging studies, particularly structural MRI, have revealed reductions in grey matter volume in brain regions such as the temporal lobe and insula. This study combines deep learning and neuroimaging for precise automatic detection of schizophrenia. Using T1-weighted coronal MRI data from three publicly accessible datasets (MCICShare, COBRE, UCLA), a DeepLabv3+ model with ResNet50-based segmentation was employed to isolate the temporal lobe and insula, achieving segmentation accuracies of 96% and 97%, respectively. Enhanced visualization of isolated regions through color-to-grayscale conversion distinguished schizophrenia patients from controls, achieving an AUC of 0.99. Our study specifically focuses on the regions critically linked to both cognitive and emotional dysfunctions in schizophrenia. These results advance the literature by demonstrating improved diagnostic performance and reliability compared to traditional clinical assessments and earlier imaging-based methods.

Indexed as

Deep LearningMagnetic Resonance ImagingNeuroimagingSchizophreniaAdultConvolutional Neural NetworksFemaleHumansMaleReproducibility of ResultsTemporal LobeContrast enhancementDeepLabv3+Deep learningGrad-CAMInsulaSANS correlationSchizophreniaSemantic segmentationStructural MRITemporal lobe

Identifiers

PMID41366658
PMCPMC12801474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.